Skip to main content
. 2022 Jun 22;5(3):647–661. doi: 10.20517/cdr.2022.23

Figure 1.

Figure 1

Direct and indirect effects of FDA-approved and developmental agents on MM cells and their interaction with other cell types within the tumor microenvironment. CAR: Chimeric antigen receptor.